VS
Vijay Shankarlal Bankda
About Vijay Shankarlal Bankda
Data last updated:
Vijay Shankarlal Bankda is a Director at Vincit Biotech International Private Limited (since 2022), Director at Synmex Pharma Private Limited (since 2022) and Managing Director at Syncom Formulations (India) Limited (since 1999), and holds 1 more current directorship. The companies operate in Pharma, Trading and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹26.12 Cr; the largest is Vincit Biotech International Private Limited at ₹13.14 Cr (FY 2025). Earlier, Vijay Shankarlal Bankda was a Director at Kva Pharma Private Limited (1996–2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vincit Biotech International Private Limited U51909MP2022PTC061970 | Director | 25 Jul 2022 | 2022 | ₹13.14 Cr (FY 2025) | Active |
| Synmex Pharma Private Limited U51909MP2022PTC061919 | Director | 21 Jul 2022 | 2022 | ₹7.09 Cr (FY 2025) | Active |
 Syncom Formulations (India) Limited L24239MH1988PLC047759 | Managing Director | 01 Dec 1999 | 1988 | ₹5.88 Cr (FY 2025) | Active |
| Sante Biotech Private Limited U51909MP2022PTC061915 | Director | 21 Jul 2022 | 2022 | ₹1.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Kva Pharma Private Limited U24232MP1996PTC010646 | Director | 25 Mar 1996 | 1996 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Shankarlal Bankda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kedarmal Shankarlal Bankda | 00023050 | Vincit Biotech International Private Limited , Synmex Pharma Private Limited and 2 more | Director |
| Ankit Jain | 05341403 | Syncom Formulations (India) Limited | Director |
| Ankit Kedarmal Bankda | 02359461 | Syncom Formulations (India) Limited | Whole-Time Director |
| Rahul Vijay Bankda | Syncom Formulations (India) Limited | Cfo | |
| Ritesh Kumar Lunkad | 10275445 | Syncom Formulations (India) Limited | Director |
| Ruchi Jindal | 09633465 | Syncom Formulations (India) Limited | Director |
| Vaishali Agrawal | Syncom Formulations (India) Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Shankarlal Bankda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Shankarlal Bankda
Vijay Shankarlal Bankda currently holds 4 directorships: Vincit Biotech International Private Limited (Director, since 25 Jul 2022, revenue ₹13.14 Cr (FY 2025)); Synmex Pharma Private Limited (Director, since 21 Jul 2022, revenue ₹7.09 Cr (FY 2025)); Syncom Formulations (India) Limited (Managing Director, since 01 Dec 1999, revenue ₹5.88 Cr (FY 2025)); Sante Biotech Private Limited (Director, since 21 Jul 2022, revenue ₹1.5 Lakh (FY 2025)).
Vijay Shankarlal Bankda was first appointed on 25 Mar 1996 as Director at Kva Pharma Private Limited. The most recent appointment on record is 25 Jul 2022 at Vincit Biotech International Private Limited.
The 4 current companies of Vijay Shankarlal Bankda that report revenue have a combined latest revenue of ₹26.12 Cr: Vincit Biotech International Private Limited ₹13.14 Cr (FY 2025); Synmex Pharma Private Limited ₹7.09 Cr (FY 2025); Syncom Formulations (India) Limited ₹5.88 Cr (FY 2025); Sante Biotech Private Limited ₹1.5 Lakh (FY 2025).
Vijay Shankarlal Bankda held 1 earlier board appointment: Kva Pharma Private Limited (Director, 25 Mar 1996 to 25 Aug 2008).
The current boards of Vijay Shankarlal Bankda's companies include Kedarmal Shankarlal Bankda (Vincit Biotech International Private Limited), Ankit Jain (Syncom Formulations (India) Limited), Ankit Kedarmal Bankda (Syncom Formulations (India) Limited), Rahul Vijay Bankda (Syncom Formulations (India) Limited), Ritesh Kumar Lunkad (Syncom Formulations (India) Limited), Ruchi Jindal (Syncom Formulations (India) Limited), among others.